scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1016189P |
P356 | DOI | 10.1371/JOURNAL.PONE.0116189 |
P932 | PMC publication ID | 4344229 |
P698 | PubMed publication ID | 25723713 |
P5875 | ResearchGate publication ID | 273787575 |
P50 | author | Haralampos Moutsopoulos | Q87896552 |
Athanasios George Tzioufas | Q92673448 | ||
P2093 | author name string | Dimitrios C Ziogas | |
Elias Zintzaras | |||
Michael Voulgarelis | |||
Clio P Mavragani | |||
Aristea Papageorgiou | |||
P2860 | cites work | Predictors of lymphoma development in primary Sjögren's syndrome | Q77525386 |
Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992 | Q77919318 | ||
Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). | Q50484229 | ||
Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study. | Q51015200 | ||
MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. | Q53548061 | ||
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. | Q55033876 | ||
Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. | Q55055463 | ||
Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors | Q56907577 | ||
Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome | Q56907636 | ||
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients | Q57012743 | ||
Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome | Q57901302 | ||
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype | Q63353115 | ||
Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS | Q71022588 | ||
Long-term followup of patients with Sjögren's syndrome | Q71634855 | ||
Probability of the development of non-Hodgkin's lymphoma in primary Sjögren's syndrome | Q71976155 | ||
Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses | Q73516588 | ||
Report of the Committee on Hodgkin's Disease Staging Classification | Q28250452 | ||
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 | ||
Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects | Q33386179 | ||
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group | Q33773306 | ||
Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed | Q33825043 | ||
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome | Q34117422 | ||
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | Q34529373 | ||
Clinical presentation and management of marginal zone lymphomas | Q34562804 | ||
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort | Q34743817 | ||
Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results | Q35534203 | ||
Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors | Q35637298 | ||
The risk of lymphoma development in autoimmune diseases: a meta-analysis | Q36313002 | ||
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium | Q36528740 | ||
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression | Q36745815 | ||
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies | Q37218079 | ||
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. | Q37653274 | ||
Increased Risk of Lymphoma in Sicca Syndrome | Q39632164 | ||
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome | Q40634492 | ||
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome | Q40650085 | ||
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. | Q42985694 | ||
Dissemination patterns in non-gastric MALT lymphoma | Q44044817 | ||
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome | Q44554302 | ||
Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome | Q46223982 | ||
Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome | Q46463584 | ||
Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study | Q46512541 | ||
Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma. | Q46866801 | ||
Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study | Q47784216 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0116189 | |
P577 | publication date | 2015-02-27 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients | |
P478 | volume | 10 |
Q41652024 | A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation |
Q33568158 | Characterization and risk estimate of cancer in patients with primary Sjögren syndrome |
Q47367551 | Clinical features and outcome of lymphoma patients with pre-existing autoimmune diseases. |
Q40785165 | Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients |
Q39177903 | Extrahepatic Manifestations of Primary Biliary Cholangitis |
Q38645847 | Is primary Sjögren's syndrome a risk factor for malignancies different from lymphomas? What does the literature highlight about it? |
Q55446969 | Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome. |
Q93347159 | Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome |
Q55284236 | Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension. |
Q38905170 | Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers |
Q90258496 | Pseudo-monoclonal gammopathy due to autoimmune disease: a case report |
Q41535448 | Pulmonary MALT Lymphoma in Patients with Sjögren's Syndrome |
Q30234992 | Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment |
Q90415297 | Role of miR200b-5p miRNA in lymphomagenesis associated with Sjögren's syndrome (SS) |
Q89669149 | Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome |
Q39019614 | Sjögren Syndrome and Other Causes of Sicca in Older Adults |
Q64921582 | Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis. |
Q52930950 | The value of fine needle aspiration cytology in the clinical management of rare salivary gland tumors. |
Q30249011 | Treatment of primary Sjögren syndrome |
Q90003803 | Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults |
Search more.